Acute Responses to Walking, Stair Climbing, and Functional Circuit Exercise
4. September 2026 aktualisiert von: Ramazan Bayer, Malatya Turgut Ozal University
Acute Metabolic, Respiratory, and Neuromotor Responses to Walking, Stair Climbing, and Functional Circuit Exercise in Sedentary Individuals: A Heart Rate-Controlled Randomized Crossover Study
This study evaluated the acute physiological responses to three different exercise modalities in sedentary young men. Participants completed walking, stair climbing, and functional circuit exercise sessions in a randomized crossover design. Each exercise session lasted 20 minutes and was performed at a target intensity of 50% heart rate reserve (±5 beats/min), with at least 72 hours between sessions.
The study compared acute respiratory, metabolic, and neuromotor responses to the three exercise modalities. Pulmonary function was assessed using spirometry, blood lactate concentration was measured using capillary blood samples, and countermovement jump performance was assessed as an indicator of neuromuscular performance. Heart rate was continuously monitored during each exercise session.
Studienübersicht
Status
Abgeschlossen
Bedingungen
Intervention / Behandlung
Studientyp
Interventionell
Einschreibung (Tatsächlich)
30
Phase
- Unzutreffend
Kontakte und Standorte
Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.
Studienorte
-
-
Malatya
-
Malatya, Malatya, Türkei (türkiye), 44100
- Malatya Turgut Ozal University
-
-
Teilnahmekriterien
Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
Akzeptiert gesunde Freiwillige
Ja
Beschreibung
Inclusion Criteria:
- Male sex.
- Aged 18-30 years.
- Classified as sedentary/insufficiently active according to the study eligibility criteria.
- Able to safely complete the exercise protocols and study assessments.
- Provided voluntary informed consent.
Exclusion Criteria:
- Current cigarette or electronic cigarette use.
- Known cardiovascular, respiratory, or metabolic disease.
- Regular medication use that could affect physiological responses to exercise.
- Acute infection within the previous 2 weeks.
- Musculoskeletal conditions that could interfere with safe participation in the exercise protocols.
- Any condition requiring medical evaluation before exercise participation.
- Inability to obtain acceptable baseline spirometry measurements according to the study procedures.
Studienplan
Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Grundlegende Wissenschaft
- Zuteilung: Zufällig
- Interventionsmodell: Crossover-Aufgabe
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: WP-SP-FCP Sequence
Participants completed the Walking Protocol first, followed by the Stair Climbing Protocol and then the Functional Circuit Protocol, with at least 72 hours between sessions.
|
Participants performed a 20-minute walking exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Andere Namen:
Participants performed a 20-minute stair climbing exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Andere Namen:
Participants performed a 20-minute functional circuit exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
The circuit consisted of chair sit-to-stand, reverse lunges, wall push-ups, high-knee marching, and low-impact mountain climbers performed on an elevated surface.
Heart rate was continuously monitored throughout the exercise session.
Andere Namen:
|
|
Experimental: WP-FCP-SP Sequence
Participants completed the Walking Protocol first, followed by the Functional Circuit Protocol and then the Stair Climbing Protocol, with at least 72 hours between sessions.
|
Participants performed a 20-minute walking exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Andere Namen:
Participants performed a 20-minute stair climbing exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Andere Namen:
Participants performed a 20-minute functional circuit exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
The circuit consisted of chair sit-to-stand, reverse lunges, wall push-ups, high-knee marching, and low-impact mountain climbers performed on an elevated surface.
Heart rate was continuously monitored throughout the exercise session.
Andere Namen:
|
|
Experimental: SP-WP-FCP Sequence
Participants completed the Stair Climbing Protocol first, followed by the Walking Protocol and then the Functional Circuit Protocol, with at least 72 hours between sessions.
|
Participants performed a 20-minute walking exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Andere Namen:
Participants performed a 20-minute stair climbing exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Andere Namen:
Participants performed a 20-minute functional circuit exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
The circuit consisted of chair sit-to-stand, reverse lunges, wall push-ups, high-knee marching, and low-impact mountain climbers performed on an elevated surface.
Heart rate was continuously monitored throughout the exercise session.
Andere Namen:
|
|
Experimental: SP-FCP-WP Sequence
Participants completed the Stair Climbing Protocol first, followed by the Functional Circuit Protocol and then the Walking Protocol, with at least 72 hours between sessions.
|
Participants performed a 20-minute walking exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Andere Namen:
Participants performed a 20-minute stair climbing exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Andere Namen:
Participants performed a 20-minute functional circuit exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
The circuit consisted of chair sit-to-stand, reverse lunges, wall push-ups, high-knee marching, and low-impact mountain climbers performed on an elevated surface.
Heart rate was continuously monitored throughout the exercise session.
Andere Namen:
|
|
Experimental: FCP-WP-SP Sequence
Participants completed the Functional Circuit Protocol first, followed by the Walking Protocol and then the Stair Climbing Protocol, with at least 72 hours between sessions.
|
Participants performed a 20-minute walking exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Andere Namen:
Participants performed a 20-minute stair climbing exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Andere Namen:
Participants performed a 20-minute functional circuit exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
The circuit consisted of chair sit-to-stand, reverse lunges, wall push-ups, high-knee marching, and low-impact mountain climbers performed on an elevated surface.
Heart rate was continuously monitored throughout the exercise session.
Andere Namen:
|
|
Experimental: FCP-SP-WP Sequence
Participants completed the Functional Circuit Protocol first, followed by the Stair Climbing Protocol and then the Walking Protocol, with at least 72 hours between sessions.
|
Participants performed a 20-minute walking exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Andere Namen:
Participants performed a 20-minute stair climbing exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Andere Namen:
Participants performed a 20-minute functional circuit exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
The circuit consisted of chair sit-to-stand, reverse lunges, wall push-ups, high-knee marching, and low-impact mountain climbers performed on an elevated surface.
Heart rate was continuously monitored throughout the exercise session.
Andere Namen:
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change in Forced Expiratory Volume in One Second (FEV1)
Zeitfenster: Baseline and 5 minutes after each exercise session
|
Forced expiratory volume in one second (FEV1) was measured by spirometry before and 5 minutes after each exercise condition.
The primary outcome was the change in FEV1 (ΔFEV1), calculated as post-exercise FEV1 minus pre-exercise FEV1 and expressed in liters (L).
Measurements were obtained following standardized spirometry procedures.
|
Baseline and 5 minutes after each exercise session
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change in Forced Vital Capacity (FVC)
Zeitfenster: Baseline and 5 minutes after each exercise session
|
Forced vital capacity (FVC) was measured by spirometry before and 5 minutes after each exercise condition.
The outcome was the change in FVC (ΔFVC), calculated as post-exercise FVC minus pre-exercise FVC and expressed in liters (L).
|
Baseline and 5 minutes after each exercise session
|
|
Change in FEV1/FVC Ratio
Zeitfenster: Baseline and 5 minutes after each exercise session
|
The FEV1/FVC ratio was assessed by spirometry before and 5 minutes after each exercise condition.
The outcome was the change in FEV1/FVC ratio (ΔFEV1/FVC), calculated as the post-exercise value minus the pre-exercise value.
|
Baseline and 5 minutes after each exercise session
|
|
Change in Peak Expiratory Flow (PEF)
Zeitfenster: Baseline and 5 minutes after each exercise session
|
Peak expiratory flow (PEF) was measured by spirometry before and 5 minutes after each exercise condition.
The outcome was the change in PEF (ΔPEF), calculated as the post-exercise PEF minus the pre-exercise PEF and expressed in liters per second (L/s).
|
Baseline and 5 minutes after each exercise session
|
|
Change in Blood Lactate Concentration
Zeitfenster: Baseline and 3 minutes after each exercise session
|
Capillary blood lactate concentration was measured before exercise and 3 minutes after each exercise condition.
The outcome was the change in blood lactate concentration (ΔLactate), calculated as the post-exercise value minus the pre-exercise value and expressed in millimoles per liter (mmol/L).
|
Baseline and 3 minutes after each exercise session
|
|
Change in Countermovement Jump Height (CMJ)
Zeitfenster: Baseline and immediately after post-exercise spirometry initiated at 5 minutes after each exercise session
|
Countermovement jump (CMJ) height was assessed before and after each exercise condition.
The outcome was the change in CMJ height (ΔCMJ), calculated as the post-exercise value minus the pre-exercise value and expressed in centimeters (cm).
|
Baseline and immediately after post-exercise spirometry initiated at 5 minutes after each exercise session
|
|
Mean Heart Rate During Exercise
Zeitfenster: During each 20-minute exercise session
|
Heart rate was continuously monitored throughout each exercise condition.
Mean heart rate was calculated across the exercise period and expressed in beats per minute (bpm).
|
During each 20-minute exercise session
|
|
Maximum Heart Rate During Exercise
Zeitfenster: During each 20-minute exercise session
|
Heart rate was continuously monitored throughout each exercise condition.
Maximum heart rate was defined as the highest heart rate recorded during the exercise period and expressed in beats per minute (bpm).
|
During each 20-minute exercise session
|
|
Time Spent in the Target Heart Rate Range
Zeitfenster: During each 20-minute exercise session
|
Heart rate was continuously monitored throughout each exercise condition.
The outcome was the percentage of exercise time during which heart rate remained within ±5 beats/min of the individualized target heart rate corresponding to 50% heart rate reserve (HRR)
|
During each 20-minute exercise session
|
Mitarbeiter und Ermittler
Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.
Sponsor
Studienaufzeichnungsdaten
Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.
Haupttermine studieren
Studienbeginn (Tatsächlich)
22. Juni 2026
Primärer Abschluss (Tatsächlich)
5. August 2026
Studienabschluss (Tatsächlich)
5. August 2026
Studienanmeldedaten
Zuerst eingereicht
1. September 2026
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
4. September 2026
Zuerst gepostet (Tatsächlich)
8. September 2026
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
8. September 2026
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
4. September 2026
Zuletzt verifiziert
1. September 2026
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 2026/205
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
NEIN
Beschreibung des IPD-Plans
Individual participant data are not planned to be shared because no data-sharing plan was established as part of the original study protocol.
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Nein
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Nein
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .